16 March 2023

GSK Stockmann advises Well Health Technologies and Horizons Ventures on Doctorly financing

GSK Stockmann has acted as advisors to Well Health Technologies, a Canadian publicly traded digital healthcare technology company based in Vancouver, and Horizons Ventures, based in Hong Kong, on the current Series A financing round for Doctorly GmbH, a software developer based in Berlin.

Well Health Technologies is a multi-channel digital health technology company and Canada’s largest owner and operator of outpatient health clinics. The company owns and operates primary healthcare facilities in Canada and the United States and also provides (SaaS) EMR services to clinics and physicians across Canada.

Horizons Ventures is an investor in some of the world’s most innovative companies, including Facebook, Waze, Spotify, Impossible Foods, Improbable and Zoom.

Berlin-based startup Doctorly, founded by Samir El-Alami, Nicklas Teicke, Anna Von Stackelberg, Sebastian Lau and Alexandru Boghean, focuses on software for medical practices. With its offer, the company wants to reduce the administrative effort in medical practices and advance the digitalisation of medical services.

In the current financing round, Doctorly raised ten million euros. Doctorly wants to invest the funds in growth in Germany and the development of new functions of the practice software. With their investment, Well Health Technologies led the financing round. Horizons Ventures was part of an investor consortium that includes other renowned venture capital firms such as The Delta Force AG, Speedinvest, UNIQA Ventures, Calm Storm and Seedcamp.

GSK Stockmann advised Well Health Technologies and Horizons Ventures with a team led by Berlin VC partner Dr Katy Ritzmann comprehensively on the financing round. The advice related in particular to  legal due diligence, in which, in addition to corporate law issues, special features of data protection and IT security law in the medical sector played a role. These aspects are of particular importance to the healthcare sector GSK Stockmann. In addition, the team negotiated the entire investment documentation.

Advisors to Well Health Technologies and Horizons Ventures:

GSK Stockmann: Dr Katy Ritzmann (lead), Dennis Gehnen, Clara López Hernando, Eda Altintas (all Venture Capital), Marie Bogutzki, Rebecca Comtesse (both Finance), Nicole Deparade (Labor Law)

Other advisors:

BMH Bräutigam: Dr. Patrick Auerbach, Jan Böhle, Sebastian Krieg (all Venture Capital)


Press contact
+49 30 203907-7763


GSK Updates
  • 02 June 2023

    GSK Update: Comprehensive VAT exemption for management of alternative investment funds (AIFs) planned in Germany

    Read more
  • 17 May 2023

    GSK Update: German Tax Aspects for Inbound Investments

    Read more
  • 05 May 2023

    GSK Update: Real Estate Investments in Germany from a Tax Perspective

    Read more
Contact person

Dr. Katy Ritzmann


+49 30 203907-422


For reasons of better readability, we use the gender-neutral generic masculine. However, the information expressly refers to all genders.

CO2 Neutral